Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis. [electronic resource]
Producer: 19960209Description: 1503-8 p. digitalISSN:- 0301-472X
- Adult
- Aged
- Bone Marrow Transplantation
- Cyclophosphamide -- therapeutic use
- Etoposide -- therapeutic use
- Female
- Graft vs Host Disease -- prevention & control
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Granulocyte-Macrophage Colony-Stimulating Factor -- therapeutic use
- Histocompatibility
- Humans
- Leukemia -- mortality
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Recombinant Proteins -- therapeutic use
- Recurrence
- Survival Rate
- Transplantation, Homologous
- Treatment Outcome
- Whole-Body Irradiation
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.